Mold-Tek Packaging Plans ₹90 Crore FY27 CapEx and Aims for ₹44-45 EBITDA/kg

Market snapshot: Mold-Tek Packaging Limited has updated its strategic business guidance following its Q1 FY27 analyst call. The rigid plastic packaging leader outlined an ambitious ₹90 crore capital expenditure program for FY27 and upgraded its operating profitability projections. Management has pivoted target focus towards high-margin segments, notably planning to decrease its paint packaging volume dependency to boost overall margins.

Data Snapshot

• Capital expenditure for FY27 is projected at ₹90 crore, which includes a ₹25–30 crore allocation designated for the Pharma vertical.
• Full-year EBITDA per kg target is revised upward to ₹44–45, exceeding the initial range of ₹42–43.
• The company aims to reduce the Paint segment's volume contribution to overall revenues from 50% to around 40% over the next 3 to 4 years.
• Operational results for Q1 FY27 showed a net sales expansion to ₹300.45 crore, crossing the ₹300 crore mark for the first time in a quarter.
• Q1 FY27 EBITDA per kg reached a historical high of ₹46.68, driven by consolidation benefits and higher capacity utilization.

What's Changed

• Full-year EBITDA per kg target upgraded to ₹44–45, compared to the initial target range of ₹42–43.
• The planned revenue share from the cyclical paint segment is set to decline to 40% from the current 50% over a 3 to 4-year horizon.
• Net sales crossed the quarterly milestone of ₹300 crore for the first time, reaching ₹300.45 crore, representing a 24.90% YoY expansion from ₹240.56 crore.

Key Takeaways

• Operational efficiency from consolidating five Hyderabad manufacturing units into two major hubs is successfully reducing processing overheads and boosting margins.
• High-margin pharmaceutical packaging is receiving prioritised capital support, with up to one-third of the total FY27 CapEx allotted to this vertical.
• A systematic 10–12% annual capacity addition plan ensures that the company can absorb incremental demand from key FMCG and food packaging clients.

SAHI Perspective

Mold-Tek Packaging's strategic pivots point to an aggressive margin optimization phase. Restructuring the Hyderabad hubs has yielded immediate fruit, as evidenced by a record-high quarterly EBITDA per kg of ₹46.68. The decision to deliberately de-risk the portfolio by lowering the volume contribution of the lower-margin paint division to 40% ensures that more capacity is freed up for high-margin segments like pharma (which saw a robust 38.75% YoY volume surge in Q1 FY27). Moving into high-value product streams and upgrading EBITDA per kg guidelines signals structural margin resilience.

Market Implications

The strategic transition from low-margin paints packaging to higher-margin food, FMCG, and pharma products is highly positive for the company's long-term return on capital. While overall volume growth of 6.25% in Q1 FY27 lagged behind full-year expectations of 10–15%, the superior product mix and higher EBITDA realizations effectively protected profitability. Strong execution on the proposed ₹90 crore CapEx will likely position the company to capture lucrative, high-margin domestic and export opportunities.

Trading Signals

Market Bias: Bullish

Operating performance is set to improve as EBITDA per kg rises toward the upgraded ₹44–45 guidance range. First-quarter revenue crossing the ₹300 crore mark for the first time, paired with a massive 38.75% YoY surge in pharma packaging volumes, establishes a strong baseline for margin expansion.

Overweight: Rigid Packaging, Specialty Pharma Packaging, FMCG Packaging

Underweight: Industrial Paint Packaging

Trigger Factors:

• Consistent delivery of EBITDA per kg above the ₹44 threshold
• Ramp-up of new manufacturing capacities funded by the ₹90 crore CapEx
• Export order inflows in the pharmaceutical packaging vertical

Time Horizon: Medium-term (3-12 months)

Industry Context

The rigid plastic packaging market in India is witnessing a transition where manufacturers are shifting capacity towards higher-barrier, high-precision packaging sectors like food and pharmaceuticals. Mold-Tek's focus on In-Mold Labeling (IML) technology and in-house mold making allows it to pivot rapidly away from commoditized packaging toward value-added segments, giving it a definitive edge over unorganized competitors.

Key Risks to Watch

• Sharp increases in polypropylene and raw polymer prices that could contract margins if price resets are delayed.
• Slowdown in downstream demand from FMCG and pharma clients impacting the utilization of the newly expanded capacities.
• Execution and regulatory audit delays in the highly stringent pharmaceutical packaging facilities.

Recent Developments

On July 27, 2026, Mold-Tek Packaging approved and reported its Q1 FY27 financial performance. Standalone net sales expanded 24.90% YoY to ₹300.45 crore, while net profit grew 14.15% to ₹25.57 crore. The operational performance was highlighted by a record EBITDA per kg of ₹46.68 and a 38.75% volume surge in the high-margin Pharma division, reflecting the early benefits of its Hyderabad plant consolidation.

Closing Insight

Mold-Tek Packaging's transition from a paint-dominated supplier to a diversified, high-margin technical packaging partner is accelerating. Backed by solid balance sheet discipline and a high-margin pharma push, the company is systematically upgrading its structural profitability. The combination of upgraded EBITDA/kg targets and disciplined CapEx execution positions MOLDTKPAC as a compelling operational efficiency story in the packaging space.

High Performance Trading with SAHI.